{"id":53946,"date":"2026-01-13T20:58:20","date_gmt":"2026-01-13T12:58:20","guid":{"rendered":"https:\/\/flcube.com\/?p=53946"},"modified":"2026-01-13T20:58:21","modified_gmt":"2026-01-13T12:58:21","slug":"abbvie-commits-100-billion-us-investment-and-trumprx-expansion-for-tariff-relief","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=53946","title":{"rendered":"AbbVie Commits $100\u202fBillion US Investment and TrumpRx Expansion for Tariff Relief"},"content":{"rendered":"\n<p><strong>AbbVie Inc.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/ABBV:NYSE\">NYSE:\u202fABBV<\/a>) announced a <strong>voluntary agreement<\/strong> with the <strong>Trump administration<\/strong> to advance drug access and affordability, committing <strong>USD\u202f100\u202fbillion<\/strong> in US\u2011based R&amp;D and manufacturing investments over the next decade while expanding <strong>TrumpRx<\/strong> direct\u2011to\u2011patient offerings in exchange for <strong>three\u2011year tariff relief<\/strong> and exemption from future federal price mandates.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-deal-structure-amp-key-terms\">Deal Structure &amp; Key Terms<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Agreement Type<\/strong><\/td><td>Voluntary pact with US government<\/td><\/tr><tr><td><strong>Investment<\/strong><\/td><td>USD $100\u202fbillion over 10 years (R&amp;D + capital\/manufacturing)<\/td><\/tr><tr><td><strong>Medicaid Pricing<\/strong><\/td><td>Commitment to low prices for Medicaid programs<\/td><\/tr><tr><td><strong>Direct\u2011to\u2011Patient<\/strong><\/td><td>TrumpRx expansion for ALPHAGAN, COMBIGAN, HUMIRA, SYNTHROID<\/td><\/tr><tr><td><strong>Tariff Relief<\/strong><\/td><td>3\u2011year exemption from US import tariffs<\/td><\/tr><tr><td><strong>Price Mandates<\/strong><\/td><td>Shielded from future federal price controls<\/td><\/tr><tr><td><strong>Confidential Terms<\/strong><\/td><td>Additional provisions not disclosed<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-direct-to-patient-drug-expansion-via-trumprx\">Direct\u2011to\u2011Patient Drug Expansion via TrumpRx<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Drug<\/th><th>Indication<\/th><th>US Patients<\/th><th>Current Annual Cost<\/th><\/tr><\/thead><tbody><tr><td><strong>HUMIRA<\/strong><\/td><td>Rheumatoid arthritis, psoriasis<\/td><td>450,000<\/td><td>$84,000<\/td><\/tr><tr><td><strong>SYNTHROID<\/strong><\/td><td>Hypothyroidism<\/td><td>28\u202fmillion<\/td><td>$180<\/td><\/tr><tr><td><strong>ALPHAGAN<\/strong><\/td><td>Glaucoma<\/td><td>2.1\u202fmillion<\/td><td>$320<\/td><\/tr><tr><td><strong>COMBIGAN<\/strong><\/td><td>Glaucoma<\/td><td>1.5\u202fmillion<\/td><td>$380<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Patient Impact:<\/strong> TrumpRx expected to reduce out\u2011of\u2011pocket costs by <strong>40\u201160\u202f%<\/strong> for uninsured\/underinsured<\/li>\n\n\n\n<li><strong>Revenue Risk:<\/strong> Direct sales may cannibalize <strong>$200\u2011300\u202fmillion<\/strong> in pharmacy channel revenue, offset by volume gains<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-context-industry-wide-tariff-relief-trend\">Market Context: Industry\u2011Wide Tariff Relief Trend<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Company<\/th><th>Agreement Date<\/th><th>Tariff Relief<\/th><th>Key Terms<\/th><\/tr><\/thead><tbody><tr><td><strong>Novartis<\/strong><\/td><td>Jan\u202f2026<\/td><td>3\u2011year<\/td><td>$50B US investment<\/td><\/tr><tr><td><strong>Merck &amp; Co.<\/strong><\/td><td>Jan\u202f2026<\/td><td>3\u2011year<\/td><td>Manufacturing expansion<\/td><\/tr><tr><td><strong>Sanofi<\/strong><\/td><td>Jan\u202f2026<\/td><td>3\u2011year<\/td><td>R&amp;D commitments<\/td><\/tr><tr><td><strong>Johnson &amp; Johnson<\/strong><\/td><td>Jan\u202f2026<\/td><td>3\u2011year<\/td><td>Pricing concessions<\/td><\/tr><tr><td><strong>AbbVie<\/strong><\/td><td>12\u202fJan\u202f2026<\/td><td>3\u2011year<\/td><td><strong>$100B US investment + TrumpRx<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Policy Framework:<\/strong> Trump administration\u2019s \u201ccarrot\u2011and\u2011stick\u201d approach links tariff relief to domestic investment and pricing commitments<\/li>\n\n\n\n<li><strong>Competitive Dynamics:<\/strong> AbbVie\u2019s <strong>$100\u202fbillion pledge<\/strong> is the <strong>largest public commitment<\/strong> to date<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-financial-impact-amp-investment-breakdown\">Financial Impact &amp; Investment Breakdown<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Investment Category<\/th><th>10\u2011Year Allocation<\/th><th>Annual Run\u2011Rate<\/th><th>Focus Areas<\/th><\/tr><\/thead><tbody><tr><td><strong>R&amp;D<\/strong><\/td><td>$60\u202fbillion<\/td><td>$6\u202fbillion<\/td><td>Oncology, immunology, neuroscience pipelines<\/td><\/tr><tr><td><strong>Manufacturing<\/strong><\/td><td>$30\u202fbillion<\/td><td>$3\u202fbillion<\/td><td>Biologics production, cell\/gene therapy facilities<\/td><\/tr><tr><td><strong>Capital Infrastructure<\/strong><\/td><td>$10\u202fbillion<\/td><td>$1\u202fbillion<\/td><td>US supply chain resilience<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Revenue Trade\u2011Off:<\/strong> Medicaid pricing concessions may reduce gross revenue by <strong>2\u20113\u202f%<\/strong> (~$1.5\u202fbillion annually), offset by tariff savings and volume growth<\/li>\n\n\n\n<li><strong>Tax Incentives:<\/strong> Qualifies for <strong>IRA manufacturing tax credits<\/strong> estimated at <strong>$8\u201112\u202fbillion<\/strong> over decade<\/li>\n\n\n\n<li><strong>Earnings Guidance:<\/strong> AbbVie reaffirms 2026 EPS guidance of $12.05\u2011$12.25, excluding one\u2011time implementation costs<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-positioning-amp-shareholder-value\">Strategic Positioning &amp; Shareholder Value<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Risk Mitigation:<\/strong> Exemption from future price mandates provides <strong>long\u2011term pricing power security<\/strong> for core franchises (HUMIRA, Skyrizi, Rinvoq)<\/li>\n\n\n\n<li><strong>Political Capital:<\/strong> Positions AbbVie as <strong>preferred partner<\/strong> in future healthcare policy negotiations<\/li>\n\n\n\n<li><strong>Supply Chain:<\/strong> Manufacturing investments reduce <strong>reliance on overseas APIs<\/strong> and insulate from geopolitical tensions<\/li>\n\n\n\n<li><strong>ESG Alignment:<\/strong> Domestic job creation (estimated <strong>15,000 new US positions<\/strong>) supports ESG ratings<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding AbbVie\u2019s investment plans, revenue impact, and regulatory benefits. Actual results may differ due to changes in US healthcare policy, tax law modifications, and competitive responses.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AbbVie Inc. (NYSE:\u202fABBV) announced a voluntary agreement with the Trump administration to advance drug access&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7],"tags":[234,853],"class_list":["post-53946","post","type-post","status-publish","format-standard","hentry","category-company","tag-abbvie","tag-nyse-abbv"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>AbbVie Commits $100\u202fBillion US Investment and TrumpRx Expansion for Tariff Relief - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"AbbVie Inc. (NYSE:\u202fABBV) announced a voluntary agreement with the Trump administration to advance drug access and affordability, committing USD\u202f100\u202fbillion in US\u2011based R&amp;D and manufacturing investments over the next decade while expanding TrumpRx direct\u2011to\u2011patient offerings in exchange for three\u2011year tariff relief and exemption from future federal price mandates.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=53946\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AbbVie Commits $100\u202fBillion US Investment and TrumpRx Expansion for Tariff Relief\" \/>\n<meta property=\"og:description\" content=\"AbbVie Inc. (NYSE:\u202fABBV) announced a voluntary agreement with the Trump administration to advance drug access and affordability, committing USD\u202f100\u202fbillion in US\u2011based R&amp;D and manufacturing investments over the next decade while expanding TrumpRx direct\u2011to\u2011patient offerings in exchange for three\u2011year tariff relief and exemption from future federal price mandates.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=53946\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-13T12:58:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-13T12:58:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=53946#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=53946\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"AbbVie Commits $100\u202fBillion US Investment and TrumpRx Expansion for Tariff Relief\",\"datePublished\":\"2026-01-13T12:58:20+00:00\",\"dateModified\":\"2026-01-13T12:58:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=53946\"},\"wordCount\":453,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"AbbVie\",\"NYSE: ABBV\"],\"articleSection\":[\"Company\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=53946#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=53946\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=53946\",\"name\":\"AbbVie Commits $100\u202fBillion US Investment and TrumpRx Expansion for Tariff Relief - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-01-13T12:58:20+00:00\",\"dateModified\":\"2026-01-13T12:58:21+00:00\",\"description\":\"AbbVie Inc. (NYSE:\u202fABBV) announced a voluntary agreement with the Trump administration to advance drug access and affordability, committing USD\u202f100\u202fbillion in US\u2011based R&D and manufacturing investments over the next decade while expanding TrumpRx direct\u2011to\u2011patient offerings in exchange for three\u2011year tariff relief and exemption from future federal price mandates.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=53946#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=53946\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=53946#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AbbVie Commits $100\u202fBillion US Investment and TrumpRx Expansion for Tariff Relief\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"AbbVie Commits $100\u202fBillion US Investment and TrumpRx Expansion for Tariff Relief - Insight, China&#039;s Pharmaceutical Industry","description":"AbbVie Inc. (NYSE:\u202fABBV) announced a voluntary agreement with the Trump administration to advance drug access and affordability, committing USD\u202f100\u202fbillion in US\u2011based R&D and manufacturing investments over the next decade while expanding TrumpRx direct\u2011to\u2011patient offerings in exchange for three\u2011year tariff relief and exemption from future federal price mandates.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=53946","og_locale":"en_US","og_type":"article","og_title":"AbbVie Commits $100\u202fBillion US Investment and TrumpRx Expansion for Tariff Relief","og_description":"AbbVie Inc. (NYSE:\u202fABBV) announced a voluntary agreement with the Trump administration to advance drug access and affordability, committing USD\u202f100\u202fbillion in US\u2011based R&D and manufacturing investments over the next decade while expanding TrumpRx direct\u2011to\u2011patient offerings in exchange for three\u2011year tariff relief and exemption from future federal price mandates.","og_url":"https:\/\/flcube.com\/?p=53946","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-01-13T12:58:20+00:00","article_modified_time":"2026-01-13T12:58:21+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=53946#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=53946"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"AbbVie Commits $100\u202fBillion US Investment and TrumpRx Expansion for Tariff Relief","datePublished":"2026-01-13T12:58:20+00:00","dateModified":"2026-01-13T12:58:21+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=53946"},"wordCount":453,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["AbbVie","NYSE: ABBV"],"articleSection":["Company"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=53946#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=53946","url":"https:\/\/flcube.com\/?p=53946","name":"AbbVie Commits $100\u202fBillion US Investment and TrumpRx Expansion for Tariff Relief - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-01-13T12:58:20+00:00","dateModified":"2026-01-13T12:58:21+00:00","description":"AbbVie Inc. (NYSE:\u202fABBV) announced a voluntary agreement with the Trump administration to advance drug access and affordability, committing USD\u202f100\u202fbillion in US\u2011based R&D and manufacturing investments over the next decade while expanding TrumpRx direct\u2011to\u2011patient offerings in exchange for three\u2011year tariff relief and exemption from future federal price mandates.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=53946#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=53946"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=53946#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"AbbVie Commits $100\u202fBillion US Investment and TrumpRx Expansion for Tariff Relief"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/53946","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=53946"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/53946\/revisions"}],"predecessor-version":[{"id":53947,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/53946\/revisions\/53947"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=53946"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=53946"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=53946"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}